Search Results | Scholarly Articles, Journals, and E-Books

Select item for more details and to access through your institution.

Masthead.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. fmi, doi. 10.1002/ddr.430340301
Publication type:
Article
General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 276, doi. 10.1002/ddr.430340305
By:
- Wagner, Heribert;
- Milavec-Krizman, Maria;
- Gadient, Fulvio;
- Menninger, Klaus;
- Schoeffter, Philippe;
- Tapparelli, Carlo;
- Pfannkuche, Hans-Jürgen;
- Fozard, John R.
Publication type:
Article
Olanzapine moderately increases conflict responding but does not produce a benzodiazepine-like cue in rat.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 317, doi. 10.1002/ddr.430340309
By:
- Nanry, Kevin P.;
- Pollard, Gerald T.;
- Howard, James L.
Publication type:
Article
Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 267, doi. 10.1002/ddr.430340304
By:
- Brune, Michael E.;
- Buckner, Steven A.;
- Polakowski, James;
- Kerwin, James F.;
- Hancock, Arthur A.
Publication type:
Article
Expression and characerization of human kainate receptor subunits in Escherichia coli and mammalian cells.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 260, doi. 10.1002/ddr.430340303
By:
- Foldes, Robert L.;
- Fantaske, Robert P.;
- Korczak, Bozena;
- Hoo, Ken H.;
- Nutt, Stephen L.;
- Kamboj, Rajender K.
Publication type:
Article
D2 and 5-HT2 modulation of psychostimulant-induced facilitation of brain stimulation reward.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 297, doi. 10.1002/ddr.430340307
By:
- Tsibulsky, Vladimir;
- Dashevsky, Boris;
- Frank, Robert A.
Publication type:
Article
Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 243, doi. 10.1002/ddr.430340302
By:
- Weisbach, Jerry A.;
- Moos, Walter H.
Publication type:
Article
Pharmacology of the human metabolites of dolasetron, an antiemetic 5-HT3 receptor antagonist.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 289, doi. 10.1002/ddr.430340306
By:
- Bigaud, Marc;
- Elands, Jack;
- Kastner, Philip R.;
- Bohnke, Rick A.;
- Emmert, Lee W.;
- Galvan, Martin
Publication type:
Article
Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase.
Published in:
Drug Development Research, 1995, v. 34, n. 3, p. 306, doi. 10.1002/ddr.430340308
By:
- Silver, Paul J.;
- Gordan, Robert J.;
- Pagani, Edward D.;
- Johnson, Judith A.;
- Maycock, Alan L.;
- Dunlap, Richard P.;
- Ferguson, Edward W.;
- Franke, Catherine A.;
- Drozd, Marion L.;
- Robinson, David T.;
- Mark Eickhoff, W.;
- Baizman, Eugene R.;
- Subramanyam, Chakrapani;
- Desai, Ranjit C.;
- Hlasta, Dennis J.;
- Newton, John F.
Publication type:
Article

Found: 9

Masthead.

General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A<sub>1</sub> receptor agonist.

Olanzapine moderately increases conflict responding but does not produce a benzodiazepine-like cue in rat.

Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo.

Expression and characerization of human kainate receptor subunits in Escherichia coli and mammalian cells.

D<sub>2</sub> and 5-HT<sub>2</sub> modulation of psychostimulant-induced facilitation of brain stimulation reward.

Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies.

Pharmacology of the human metabolites of dolasetron, an antiemetic 5-HT<sub>3</sub> receptor antagonist.

Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase.